DURING THE SHOW, IN ITS ENTIRETY. This is an example, given here to the world. For instance, in CAR T-cell therapy, T cells are taken from a patient, programmed to recognize a specific cancer antigen, then returned to the patient. But there are many cancer antigens, and physicians sometimes need to guess which ones will be most potent. This essentially turns on training T cells to recognize cancer via processes that more closely mimic the way things naturally occur in the body — like the way a vaccine teaches the immune system to recognize pathogens. T cells learn to recognize pathogens because special antigen presenting cells (APCs) gather pieces of the pathogen and show them to the T cells in a way that tells the T cells, “Here is what the pathogen looks like — go get it.” What we offer is something similar in cancer, which is for APCs to gather up the many antigens that characterize a cancer cell. That way, instead of T cells being programmed to attack one or a few antigens, they are trained to recognize many cancer antigens and are more likely to wage a multi-pronged attack on the cancer. Multaeity in Unity. Now that researchers have become adept at transforming one kind of cell into another, we merely suggest that if they just turned cancer cells into a type of APC called macrophages, those would be naturally adept at teaching T cells what to attack. In this show we tell just how. Oncologists take note!